BackAcelyrin Overview

Acelyrin Total Liabilities

Latest total liabilities for SLRN: $29M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$29.27M
45.20% YoYΔ $-24.14M vs prior year quarter

Peer average

Loading

Acelyrin Total Liabilities History

Loading

Acelyrin vs. peers: Total Liabilities Comparison

Loading

Acelyrin Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Acelyrin (SLRN) FAQ

Acelyrin's total liabilities stands at $29M as of March 2025. That compares with $53M in the prior-year period — down 45.2% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Acelyrin reported $29M in total liabilities versus $53M a year earlier — a 45.2% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $53M in the prior-year period — down 45.2% year over year. Sustained growth in total liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Acelyrin's total liabilities evolved across reporting periods, while the comparison chart places SLRN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.